Article Details
Retrieved on: 2024-10-07 17:04:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Pfizer's stock performance and strategic efforts under CEO Albert Bourla, despite significant contributions through COVID-19 vaccine development with BioNTech. It links to investment and research pursuits, including the Seagen acquisition and partnerships.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here